Angle News - AGL

Best deals to access real time data!
Real-time Level 1 for London Stock Exchange
Monthly Subscription
for only
Real-time Level 2 for London Stock Exchange
Monthly Subscription
for only
Real-time London Stock Exchange & FTSE
Monthly Subscription
for only
VAT not included
Stock Name Stock Symbol Market Stock Type
Angle Plc AGL London Ordinary Share
  Price Change Price Change % Stock Price Last Trade
-2.50 -2.37% 103.00 09:44:56
Open Price Low Price High Price Close Price Previous Close
105.00 102.50 105.50 103.00 105.50
more quote information »
Industry Sector

Recent News

Date Time Source Heading
6/23/202212:24UKREGAngle PLC Issue of Equity
6/22/202204:01ALNCAngle wins cancer monitoring contract for Parasortix system
6/22/202201:00UKREGAngle PLC Secured contract from pharma services customer
6/16/202210:55ALNCTRADING UPDATES: Valereum opens NFT market; Conygar..
6/16/202201:00RNSNONAngle PLC Predicting immunotherapy response in SCLC
6/14/202214:13ALNCIN BRIEF: Angle's Parsortix performs well on prostate cancer..
6/14/202201:00RNSNONAngle PLC Potential role of invasive cellular protrusions
5/30/202209:21ALNCIN BRIEF: Angle partners with US urology group for..
5/30/202201:01UKREGAngle PLC Partnership with major United States urology group
5/27/202215:25ALNCTRADING UPDATES: Savannah Energy to develop new projects in..
5/27/202201:01RNSNONAngle PLC Molecular characterisation of CTCs
5/25/202215:19ALNCIN BRIEF: Angle shares rocket as Parasortix receives US FDA..
5/25/202210:35UKREGAngle PLC Price Monitoring Extension
5/25/202207:20DJNAngle's Parsortix System Gets U.S. Approval; Shares Jump
5/25/202206:30UKREGAngle PLC ANGLE receives FDA clearance for Parsortix
5/20/202203:48ALNCIN BRIEF: Cancer study using Angle's Parasortix secures..
5/20/202201:01RNSNONAngle PLC Prostate Cancer UK funds new study using Parsortix
4/28/202210:10ALNCEARNINGS UPDATES: Brave Bison notes first profit; Angle..
4/28/202201:02UKREGAngle PLC Preliminary Results
4/20/202201:11UKREGAngle PLC Notice of Preliminary Results and Webcast
4/14/202201:11RNSNONAngle PLC Poster on Parsortix system presented at AACR 2022
4/01/202207:25ALNCTRADING UPDATES: Yooma, Love Hemp in UK boost; Peel Hunt..
4/01/202201:01RNSNONAngle PLC Identifying drug targets in cancer metastasis
3/29/202214:29ALNCIN BRIEF: Angle's Parsortix can help with cancer treatment..
3/29/202201:01RNSNONAngle PLC Rapid information on patient response to therapies
3/25/202213:51ALNCTRADING UPDATES: Europa eyes fundraise; Eastinco extends..
3/25/202202:00RNSNONAngle PLC Identifying therapeutic targets in TNBC patients
3/18/202215:38ALNCTRADING UPDATES: Angle US lab boost; Corcel to capitalise on..
3/15/202202:00RNSNONAngle PLC Update on laboratory accreditation
3/09/202210:41UKREGAngle PLC Second Price Monitoring Extn
3/09/202210:36UKREGAngle PLC Price Monitoring Extension
3/02/202212:29UKREGAngle PLC Holding(s) in Company
2/18/202211:13UKREGAngle PLC Issue of Equity
1/21/202206:25ALNCTAKING AIM: Berenberg hails Angle's cancer diagnosis..
1/21/202204:57ALNCStudy shows potential for Angle's Parsortix system in..
1/21/202201:00RNSNONAngle PLC Potential in immunotherapy treatment selection
1/17/202209:16ALNCAngle says Parsortix system could replace cancer tissue..
1/17/202201:01RNSNONAngle PLC Concordance of Parsortix with tissue biopsy
1/13/202206:06ALNCAngle cancer study delayed as accreditation process for labs..
1/13/202201:00UKREGAngle PLC Update on lab accreditation and ovarian study
1/10/202213:34ALNCTRADING UPDATES: Harvest Minerals sales jump; Quartix..
1/10/202201:00RNSNONAngle PLC Insight into drug resistance in NSCLC
12/22/202112:29UKREGAngle PLC Issue of Equity
12/01/202112:10UKREGAngle PLC Issue of Equity
12/01/202101:00RNSNONAngle PLC Parsortix in RNA analysis of CTCs as tool in NSCLC
11/26/202111:33UKREGAngle PLC Issue of Equity
11/17/202104:32UKREGAngle PLC Issue of Equity
11/15/202108:15ALNCEXECUTIVE CHANGES: Halma hires non-exec; Diurnal names new..
11/15/202101:00UKREGAngle PLC Issue of LTIP Options and Share Options
11/12/202111:51UKREGAngle PLC Issue of Equity
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220626 11:08:28